Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

Similar articles for PubMed (Select 24691683)

1.

Alternatives to carbapenems for infections caused by ESBL-producing Enterobacteriaceae.

Pilmis B, Parize P, Zahar JR, Lortholary O.

Eur J Clin Microbiol Infect Dis. 2014 Aug;33(8):1263-5. doi: 10.1007/s10096-014-2094-y. Epub 2014 Apr 2. No abstract available.

PMID:
24691683
2.

The challenges of carbapenemase-producing Enterobacteriaceae and infection prevention: protecting patients in the chaos.

Savard P, Carroll KC, Wilson LE, Perl TM.

Infect Control Hosp Epidemiol. 2013 Jul;34(7):730-9. doi: 10.1086/671003. Epub 2013 May 22. No abstract available.

PMID:
23739078
3.

The efficacy of cefmetazole against pyelonephritis caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae.

Doi A, Shimada T, Harada S, Iwata K, Kamiya T.

Int J Infect Dis. 2013 Mar;17(3):e159-63. doi: 10.1016/j.ijid.2012.09.010. Epub 2012 Nov 8.

4.

Outcome of urinary tract infections caused by extended spectrum β-lactamase-producing Enterobacteriaceae in children.

Tratselas A, Iosifidis E, Ioannidou M, Saoulidis S, Kollios K, Antachopoulos C, Sofianou D, Roilides EJ.

Pediatr Infect Dis J. 2011 Aug;30(8):707-10. doi: 10.1097/INF.0b013e31820d7ec4.

PMID:
21248655
5.

Prevalence of extended-spectrum beta-lactamase-producing Enterobacteriaceae in Bahrain.

Bindayna KM, Senok AC, Jamsheer AE.

J Infect Public Health. 2009;2(3):129-35. doi: 10.1016/j.jiph.2009.04.005. Epub 2009 Sep 18.

PMID:
20701872
6.

Temocillin use in England: clinical and microbiological efficacies in infections caused by extended-spectrum and/or derepressed AmpC β-lactamase-producing Enterobacteriaceae.

Balakrishnan I, Awad-El-Kariem FM, Aali A, Kumari P, Mulla R, Tan B, Brudney D, Ladenheim D, Ghazy A, Khan I, Virgincar N, Iyer S, Carryn S, Van de Velde S.

J Antimicrob Chemother. 2011 Nov;66(11):2628-31. doi: 10.1093/jac/dkr317. Epub 2011 Aug 2.

7.

Extended-spectrum beta-lactamases. An overview.

Patterson JE.

Postgrad Med. 2001 Feb;109(2 Suppl):32-8. doi: 10.3810/pgm.02.2001.suppl12.63. Review.

PMID:
19667555
8.

Distribution of ESBL-producing enterobacteria associated to community-acquired monomicrobial urinary tract infections and antimicrobial susceptibility trends over a 9-year period.

Dias VC, da Silva VL, Firmo Ede O, Bastos LQ, Bastos AN, Bastos RV, Diniz CG.

J Chemother. 2012 Jun;24(3):178-81. doi: 10.1179/1973947812Y.0000000006. No abstract available.

PMID:
22759764
9.

Carbapenem-resistant enterobacteriaceae: an emerging problem in children.

Logan LK.

Clin Infect Dis. 2012 Sep;55(6):852-9. doi: 10.1093/cid/cis543. Epub 2012 Jun 14. Review.

10.

Global spread of New Delhi metallo-β-lactamase 1.

Bogaerts P, Verroken A, Jans B, Denis O, Glupczynski Y.

Lancet Infect Dis. 2010 Dec;10(12):831-2. doi: 10.1016/S1473-3099(10)70278-4. No abstract available.

PMID:
21109171
11.

Extended-spectrum beta-lactamases: implications for the clinical laboratory and therapy.

Harada S, Ishii Y, Yamaguchi K.

Korean J Lab Med. 2008 Dec;28(6):401-12. doi: 10.3343/kjlm.2008.28.6.401. Review.

13.

Emergence of carbapenem-resistant OXA-48 carbapenemase-producing Enterobacteriaceae in Tunisia.

Saïdani M, Hammami S, Kammoun A, Slim A, Boutiba-Ben Boubaker I.

J Med Microbiol. 2012 Dec;61(Pt 12):1746-9. doi: 10.1099/jmm.0.045229-0. Epub 2012 Aug 23.

PMID:
22918869
14.

The outcome of treating ESBL infections with carbapenems vs. non carbapenem antimicrobials.

Trivedi M, Patel V, Soman R, Rodriguez C, Singhal T.

J Assoc Physicians India. 2012 Aug;60:28-30. Erratum in: J Assoc Physicians India. 2012 Dec;60:20. J Assoc Physicians India. 2012 Sep;60:54. Trivedi, Mayur [corrected to Trivedi, Mayuri].

PMID:
23405518
15.

Global spread of New Delhi metallo-β-lactamase 1.

Poirel L, Hombrouck-Alet C, Freneaux C, Bernabeu S, Nordmann P.

Lancet Infect Dis. 2010 Dec;10(12):832. doi: 10.1016/S1473-3099(10)70279-6. No abstract available.

PMID:
21109172
16.

[Extended-spectrum beta-lactamase producing-enterobacteriaceae].

Mariani-Kurkdjian P, Doit C, Bingen E.

Arch Pediatr. 2012 Nov;19 Suppl 3:S93-6. doi: 10.1016/S0929-693X(12)71280-0. French.

PMID:
23178141
17.

[ESBL--increasing resistance problems. Cephalosporins no longer obvious choice in diffuse infections].

Hallgren H, Gustafsson I, Ripa T.

Lakartidningen. 2007 Dec 19;104(51-52):3883-5. Swedish. No abstract available.

PMID:
18232531
18.

Ertapenem for the treatment of urinary tract infections caused by extended-spectrum β-lactamase-producing bacteria in children.

Dalgic N, Sancar M, Bayraktar B, Dincer E, Pelit S.

Scand J Infect Dis. 2011 May;43(5):339-43. doi: 10.3109/00365548.2011.553241. Epub 2011 Jan 28.

PMID:
21271945
19.

Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern.

Pitout JD, Laupland KB.

Lancet Infect Dis. 2008 Mar;8(3):159-66. doi: 10.1016/S1473-3099(08)70041-0. Review.

PMID:
18291338
20.

Risk associated with a systematic search of extended-spectrum β-lactamase-producing Enterobacteriaceae.

Prinapori R, Guinaud J, Khalil A, Lecuyer H, Gendrel D, Lortholary O, Nassif X, Viscoli C, Zahar JR.

Am J Infect Control. 2013 Mar;41(3):259-60. doi: 10.1016/j.ajic.2012.03.035. Epub 2012 Oct 11.

PMID:
23062579
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk